Erratum: Disruption of Myc-Max Heterodimerization with Improved Cell-Penetrating Analogs of the Small Molecule 10074-G5

Oncotarget. 2018 Oct 12;9(80):35196. doi: 10.18632/oncotarget.26241.

Huabo Wang¹, Jay Chauhan², Angela Hu¹, Kelsey Pendleton¹, Jeremy L Yap², Philip E Sabato³, Jace W Jones², Mariarita Perri⁴, Jianshi Yu², Erika Cione⁴, Maureen A Kane^{2

5}, Steven Fletcher^{2

5}, Edward V Prochownik^{1

6

7}

¹ Section of Hematology/Oncology, Children's Hospital of Pittsburgh of UPMC.
² Department of Pharmaceutical Sciences, University of Maryland School of Pharmacy, Baltimore, MD, USA.
³ PharmD Program, University of Maryland School of Pharmacy, Baltimore, MD, USA.
⁴ Department of Pharmaco-Biology, University of Calabria, Rende (CS), Italy.
⁵ University of Maryland Marlene and Stewart Greenebaum Cancer Center, Baltimore, MD, USA.
⁶ Department of Microbiology and Molecular Genetics, The University of Pittsburgh School of Medicine.
⁷ The University of Pittsburgh Cancer Institute, Pittsburgh, PA.

Abstract

[This corrects the article DOI: 10.18632/oncotarget.1108.].